Evidence map›Paper›PMID 35895989›Full record

ReviewBrazilian journal of cardiovascular surgery2022

Mechanical Circulatory Assist Devices: Which Is the Best Device as Bridge to Heart Transplantation?

Adriana Natucci Hette, Marcelo Luiz Peixoto Sobral

Open access · diamondAbstract readReview
In one paragraph

Review in Brazilian journal of cardiovascular surgery, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.5field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Adriana Natucci HetteFaculdade de Medicina, Centro Universitário Faculdade das Américas, São Paulo, São Paulo, Brazil.
Marcelo Luiz Peixoto SobralFaculdade de Medicina, Centro Universitário Faculdade das Américas, São Paulo, São Paulo, Brazil.
Beneficência Portuguesa de São Paulo · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionHeart transplantation is the recommended treatment method for patients with advanced heart failure that is refractory to clinical treatment. Due to the progressive severity of these patients and the impossibility of performing the transplant in a short term, there are mechanical circulatory assist devices that can offer necessary hemodynamic support and clinical stability in the period preceding the heart transplant surgery. The present study aims to address and describe the main devices used as bridges for heart transplantation, as well as to analyze their advantages and disadvantages.

methodsThis work is a literature review, developed with scientific production in the period from 2010 to 2020, that focus on circulatory assist devices as a bridge for heart transplantation.

resultsThese devices are characterized as a bridge for transplantation. Short-term or temporary devices are those used for hemodynamic support to stabilize the individual clinically in the presence of refractory cardiogenic shock. And long-term devices are indicated for stable patients with long-term strategic planning.

conclusionAccording to the present study, it is possible to observe that there is a wide variety of devices available on the market, enabling the most appropriate choice according to the patient's need.

Indexed as

Extracorporeal Membrane OxygenationHeart-Assist DevicesHeart FailureHeart TransplantationHumansShock, CardiogenicExtracorporeal Membrane Oxygenation.Heart FailureHeart Transplantation

Identifiers

PMID35895989
PMCPMC9670353
OpenAlexW4288752529

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.